info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Post-Traumatic Stress Disorder Treatment Market By Treatment Type (Pharmacological Therapy, Non-Pharmacological Therapy, Combination Therapy); By Therapeutic Class (SSRIs, Antipsychotics, Beta-Blockers, Benzodiazepines, Others); By End User (Hospitals & Clinics, Mental Health Institutions, Military & Veterans Affairs Facilities, Digital Therapy Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Post-Traumatic Stress Disorder ( PTSD ) Treatment Market will witness a robust CAGR of 6.9% , valued at $8.4 billion in 2024 , and is exp... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Prostate Cancer Therapeutics Market By Therapy Type (Hormonal Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Radiopharmaceuticals); By Stage (Localized, Advanced/Metastatic, Castration-Resistant); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Prostate Cancer Therapeutics Market will witness a robust CAGR of 9.8 % , valued at $17.8 billion in 2024 , and is expected to appreciate... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Ulcerative Colitis Treatment Market By Drug Class (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, JAK Inhibitors, Others); By Disease Type (Mild, Moderate, Severe); By Route of Administration (Oral, Injectable, Rectal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ulcerative Colitis Treatment Market is projected to witness a robust CAGR of 6.3% , valued at $7.9 billion in 2024 , and is expected to appreciate and reach $11.4 ... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Peptide Therapeutics Market By Type (Innovative Peptides, Generic Peptides); By Route of Administration (Parenteral, Oral, Others); By Application (Metabolic Disorders, Cancer, Cardiovascular Diseases, Infectious Diseases, Gastrointestinal Disorders, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peptide Therapeutics Market will witness a robust CAGR of 7.8% , valued at $ 32.2 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Dry Eye Syndrome Treatment Market By Product Type (Artificial Tears, Anti-Inflammatory Drugs, Secretagogues, Autologous Serum Eye Drops, Punctal Plugs, Devices); By Disease Type (Evaporative, Aqueous Deficient, Mixed); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dry Eye Syndrome Treatment Market will witness a robust CAGR of 8.4 % , valued at $ 7.5 billion in 2024 , and is ex... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Non-Small Cell Lung Cancer Therapeutics Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiotherapy & Others); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Small Cell Lung Cancer Therapeutics Market will witness a robust CAGR of 9.4% , valued at $23.8 billion in 2024 , expected to appreciate and reach $40.8 billio... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Acute Myeloid Leukemia Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation, Others); By Route of Administration (Oral, Injectable); By End User (Hospitals, Specialty Cancer Clinics, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Myeloid Leukemia Treatment Market will witness a strong CAGR of 11.2 %, valued at $ 5.3Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Microbiome Therapeutics Market By Product Type (Live Biotherapeutic Products, Prebiotics & Postbiotics, Fecal Microbiota Transplantation); By Application (Gastrointestinal Disorders, Oncology, Metabolic Diseases, Neurological Disorders, Autoimmune Conditions); By Route of Administration (Oral, Rectal, Enteric-Coated, Others); By End User (Hospitals, Academic Institutions, Biotech Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microbiome Therapeutics Market will witness a robust CAGR of 31.8% , valued at $1.67 billion in 2024 , and is expected to appreciate and reach $10.83 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Duodenal Ulcer Treatment Market By Drug Class (Proton Pump Inhibitors, H2 Receptor Antagonists, Antibiotics, Protective Agents); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Duodenal Ulcer Treatment Market will witness a robust CAGR of 7.2 % valued at USD 4.3 billion in 2024 , expected to appreciate and reach USD 6.1 b... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Cerebral Infarction Treatment Market By Treatment Type (Pharmacological Interventions [Thrombolytics, Antiplatelet Agents, Anticoagulants, Neuroprotective Agents], Surgical Procedures [Mechanical Thrombectomy, Carotid Endarterectomy, Decompressive Hemicraniectomy], Supportive and Adjunctive Care); By Mode of Administration (Intravenous, Oral, Intra-Arterial); By End User (Hospitals and Stroke Centers, Ambulatory Surgical Centers, Specialty Neurology Clinics, Rehabilitation Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cerebral Infarction Treatment Market will witness a robust CAGR of 9.35 % , valued at approximately USD 9.4 billion in 2024 , expected to... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Acinetobacter Pneumonia Therapeutics Market By Drug Class (β-lactams, Polymyxins, Carbapenems, Sulbactam Combinations, Novel Agents); By Route of Administration (Intravenous, Oral, Inhalation); By End User (Hospitals, ICUs, ASCs, Military Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acinetobacter Pneumonia Therapeutics Market will witness a promising CAGR of 7.6% , valued at $1.12 billion in 2024 , and is projected to... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Spinal Muscular Atrophy (SMA) Treatment Market By Treatment Type (Gene Therapy, Antisense Oligonucleotides, Small Molecule Drugs, Supportive Therapy); By Disease Type (Type I, Type II, Type III, Type IV); By Route of Administration (Intrathecal, Intravenous, Oral); By End User (Hospitals & Clinics, Homecare Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Spinal Muscular Atrophy ( SMA ) Treatment Market will witness a robust CAGR of 13.2 %, valued at $2.14 bill... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Uveitis Treatment Market By Drug Class (Corticosteroids, Immunosuppressive Agents, Biologics, Cycloplegics, Antimicrobials); By Disease Type (Anterior, Intermediate, Posterior, Panuveitis); By Route of Administration (Topical, Oral, Injectable, Implants); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Uveitis Treatment Market will witness a robust CAGR of 6.8% , valued at $812.4 million in 2024 , expected to appreciate and reach $1.21 billion by 2030 , ... Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Rosacea Treatment Market By Treatment Type (Topical Medications, Oral Antibiotics, Laser & Light Therapies, Biologics & Others, Cosmeceuticals & OTC); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Aesthetic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rosacea Treatment Market will witness a robust CAGR of 5.6 % , valued at $ 2.36 billion in 2024 , and i... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Stroke Management Market By Product Type (Diagnostics, Therapeutic Devices, Medications, Rehabilitation Solutions); By Application (Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attack); By End User (Hospitals & Stroke Centers, ASCs, Rehabilitation Facilities, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stroke Management Market will witness a robust CAGR of 6.4% , valued at USD 31.5 billion in 2024 , expected to appreciate and reach USD 48.43Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Stomach Cancer Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Cancer Type (Adenocarcinoma, Gastrointestinal Stromal Tumor, Lymphoma, Carcinoid Tumors); By End User (Hospitals, Specialty Cancer Clinics, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stomach Cancer Treatment Market will witness a robust CAGR of 7.2% , valued at USD 6.8 billion in 2024 , and is expected to appreciate and reach USD 10.4 billion b... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Prediabetes Market By Product Type (Diagnostic Solutions, Pharmacologic Treatments, Digital Therapeutics & Lifestyle Programs, Nutraceuticals); By Application (Screening & Risk Stratification, Disease Management & Prevention, Patient Engagement & Adherence Support); By End User (Hospitals & Specialty Clinics, Primary Care Settings, Homecare & Self-Testing, Employer & Community Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

INTRODUCTION AND STRATEGIC CONTEXT

The Global Prediabetes Market will witness a robust CAGR of 8.6%, valued at $140.2 billion in 2024, expected to appreciate and reach $229.7 billion by 2030, confirms Strategic Market Research.

&nbs... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Peanut Allergy Treatment Market By Treatment Type (Immunotherapy [Oral, Epicutaneous, Sublingual], Biologic Therapy [Anti-IgE, Anti-IL Agents], Emergency Medication, Adjunct Therapy); By Route of Administration (Oral, Epicutaneous, Injectable, Sublingual); By Age Group (Pediatric, Adolescents, Adults); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peanut Allergy Treatment Market will witness a robust CAGR of 10.7% , valued at USD 680 million in 2024 , expected to appreciate and reach USD 1.25 billion by 2030... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Onychomycosis Treatment Market By Treatment Type (Topical, Oral, Laser, Combination); By Infection Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Total Dystrophic); By Drug Type (Prescription, OTC, Natural Remedies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Onychomycosis Treatment Market will witness a robust CAGR of 7.8% , valued at $ 3.5 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Myasthenia Gravis Treatment Market By Treatment Type (Medication-Based Therapy, Monoclonal Antibodies, Plasma-Based Therapies, Surgical Intervention); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics & Infusion Centers, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myasthenia Gravis Treatment Market will witness a robust CAGR of 7.1% , valued at $1.46 billion in 2024 , and is expected to appreciate and reach $2.35 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Cellular Rejuvenation Therapeutics Market By Therapy Type (Gene Therapy & Epigenetic Reprogramming, Senolytic Therapies, Stem Cell-Based Therapies, Exosome and Extracellular Vesicle Therapies); By Application (Neurodegenerative Diseases, Ophthalmology, Dermatology & Aesthetics, Musculoskeletal Disorders, Cardiovascular and Metabolic Disorders); By Delivery Mechanism (Systemic, Localized, Genetic Delivery); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Cellular Rejuvenation Therapeutics Market is poised for a transformative run, advancing at a CAGR of 19.6%, with a valuation of USD 1.34 billion in 2024, expected to re... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Organoid-Based Therapeutic Implants Market By Organoid Type (Liver Organoids, Retinal Organoids, Intestinal Organoids, Pancreatic Organoids); By Application (Ophthalmology, Hepatology, Gastroenterology, Endocrinology, Nephrology); By End User (Academic Medical Centers, Tertiary Hospitals, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Organoid-Based Therapeutic Implants Market is on track to grow at a CAGR of 27.8%, reaching USD 1.36 billion by 2030, up from an estimated USD 312.5 million in ... Read More

Published Date: Oct-2025 | No Of Pages:191 | $ 4485

Psoriasis Treatment Market By Drug Class (Biologics, Topical Therapies, Systemic Non-biologics, Biosimilars); By Route of Administration (Injectable, Oral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Psoriasis Treatment Market will witness a robust CAGR of 8.1% , valued at USD 32.5 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Androgenetic Alopecia Market By Product Type (Oral Pharmaceuticals, Topical Solutions, Hair Transplant Devices & Procedures, Regenerative Therapies, Cosmetic Camouflaging Products); By Gender (Male, Female); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Androgenetic Alopecia Market will witness a robust CAGR of 6.8% , valued at approximately $8.4 billion in 2024 , expecte... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Invasive Ductal Carcinoma Treatment Market By Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Hormonal Therapy, Targeted Therapy, Immunotherapy); By Therapy Modality (Monotherapy, Combination Therapy, Adjuvant Therapy, Neoadjuvant Therapy); By End User (Hospitals, Cancer Specialty Clinics, ASCs, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Invasive Ductal Carcinoma Treatment Market will witness a robust CAGR of 7.9% , valued at $17.6 billion in 2024 , expected to appreciate and reach $27.8 billion by... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Duchenne Muscular Dystrophy Treatment Market By Therapy Type (Corticosteroids, Exon-Skipping Therapies, Gene Therapy, Others); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Duchenne Muscular Dystrophy (DMD) Treatment Market will witness a robust CAGR of 13.8% , valued at $Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Systemic Lupus Erythematosus Treatment Market By Drug Class (Antimalarials, NSAIDs, Corticosteroids, Immunosuppressants, Biologics and Targeted Therapies); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Systemic Lupus Erythematosus Treatment Market will witness a robust CAGR of 7.9% , valued at $3.65 billion in 2024, expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Chemotherapy-Induced Neutropenia Treatment Market By Product Type (G-CSFs, Biosimilars, Antibiotics & Antifungals, Others); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Oncology Clinics, Homecare Settings, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chemotherapy-Induced Neutropenia (CIN) Treatment Market will witness a robust CAGR of 6.8%, valued at $12.3 billion in 2024 , and is expe... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Epithelioma Treatment Market By Treatment Type (Surgical Intervention, Radiation Therapy, Chemotherapy, Immunotherapy & Targeted Therapy, Photodynamic Therapy); By Cancer Type (Basal Cell Carcinoma, Squamous Cell Carcinoma, Transitional Cell Carcinoma, Other Rare Epitheliomas); By Route of Administration (Oral, Intravenous, Topical, Intralesional); By End User (Hospitals & Specialty Cancer Centers, Ambulatory Surgical Centers, Dermatology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Epithelioma Treatment Market will witness a robust CAGR of 9.1% , valued at USD 2.1 billion in 2024, ex... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Opioid Use Disorder Treatment Market By Product Type (Medication-Assisted Treatment, Behavioral Therapy & Counseling, Digital Therapeutics); By Route of Administration (Oral, Sublingual, Injectable); By Treatment Setting (Outpatient, Residential/Inpatient, Telehealth); By Distribution Channel (Specialized Opioid Treatment Programs, Hospitals & Clinics, Retail Pharmacies, Online Pharmacies & Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Opioid Use DisorderTreatment Market will witness a robust CAGR of 7.3% , valued at $5.4 billion in 2024, expected to app... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Pruritus Therapeutics Market By Drug Class (Antihistamines, Corticosteroids, Calcineurin Inhibitors, Opioid Receptor Modulators, Biologic Therapies); By Route of Administration (Topical, Oral, Injectable); By Disease Type (Atopic Dermatitis, Chronic Kidney Disease–Associated Pruritus, Psoriasis, Cholestatic Pruritus, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pruritus Therapeutics Market will witness a robust CAGR of 5.8% , valued at $7.4 billion in 2024 , expected to appreciate and reach $10.4 billion by 2030 ... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485

Hearing Loss Disease Treatment Market By Treatment Type (Devices, Pharmaceuticals, Surgery, Gene & Cell Therapies); By Hearing Loss Type (Sensorineural, Conductive, Mixed); By End User (Hospitals & ENT Clinics, Ambulatory Surgical Centers, Hearing Aid Retail Chains, Teleaudiology Platforms, Academic & Research Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hearing Loss Disease Treatment Market will witness a robust CAGR of 8.4 %, valued at $13.4 billion in 2024 , and is expected to appreciat... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Multiple Sclerosis Therapeutics Market By Drug Class (Immunomodulators, Oral Agents, Monoclonal Antibodies, Others); By Route of Administration (Oral, Injectable, Intravenous Infusion); By Disease Type (Relapsing-Remitting MS, Secondary Progressive MS, Primary Progressive MS); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Multiple Sclerosis Therapeutics Market will witness a robust CAGR of 6.8% , valued at approximately $28.7 billion in 2024 , expected to appreciate and rea... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Microsclerotherapy Treatment Market By Treatment Type (Liquid Microsclerotherapy, Foam-Based Microsclerotherapy); By Vein Location (Lower Limb Veins, Facial/Upper Body Veins); By End User (Dermatology Clinics, Aesthetic Clinics & Medspas, Ambulatory Surgical Centers, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Microsclerotherapy Treatment Market will grow at a steady CAGR Of 5.8% , reaching a projected value of USD 111.3 Million By 2030 , up fro... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Ischemic Hepatitis Treatment Market By Treatment Type (Supportive Therapy, Antioxidants & Hepatoprotective Agents, Investigational Therapeutics); By Clinical Setting (Cardiogenic Shock, Septic Shock, Major Surgery & Transplant); By End User (Tertiary Hospitals, Academic Medical Centers, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ischemic Hepatitis Treatment Market is projected to reach USD 3.4 Billion By 2030 , up from USD 1.9 Billion In 2024 , growing at a CAGR Of 9.8% over the f... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Anophthalmia and Microphthalmia Market By Treatment Type (Surgical Interventions, Ocular Prosthetics, Pharmacologic Therapies, Gene & Stem Cell Therapies); By Disease Severity (Bilateral, Unilateral, Syndromic); By End User (Children’s Hospitals, Prosthetic Clinics, Specialty Clinics, Genetic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anophthalmia And Microphthalmia Market is projected to expand at a CAGR Of 7.1%, with an estimated value of USD 352.4 Million In 2024 , e... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Memory Disorders Market By Disorder Type (Alzheimer’s Disease, Mild Cognitive Impairment, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia); By Diagnostic Method (Neuroimaging, Biomarker Testing, Cognitive Assessment Tools, Genetic Testing); By Treatment Type (Cholinesterase Inhibitors, NMDA Antagonists, Disease-Modifying Therapies, Cognitive/Behavioral Interventions); By End User (Hospitals & Memory Clinics, Primary Care Providers, Long-Term Care Facilities, Home-Based Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Memory Disorders Market is projected to grow at a CAGR of 6.7% , reaching an estimated value of USD 10.9 billion in 2024 and poised to cross USD 16.2 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Obstructive Uropathy Treatment Market By Treatment Type (Ureteral Stents, Percutaneous Nephrostomy, Catheterization, Surgical Intervention, Pharmacological Management); By Cause (Kidney Stones, Benign Prostatic Hyperplasia, Urological Cancers, Congenital Malformations, Neurogenic Bladder, Post-Surgical Complications); By End User (Hospitals, Urology Clinics, Ambulatory Surgical Centers, Dialysis Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Obstructive Uropathy Treatment Market will expand at a steady CAGR Of 6.5% , valued at USD 3.1 Billion In 2024 and projected to reach USD 4.6 Billion By 2030Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Herpes Zoster Ophthalmicus Market By Treatment Type (Antivirals, Corticosteroids, Pain Management, Adjunctive Therapies); By Route of Administration (Oral, Topical, Injectable); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Herpes Zoster Ophthalmicus Market will witness a steady CAGR Of 6.1%, valued at USD 1.4 Billion In 2024 , and expected to reach U... Read More

Published Date: OCT-2025 | No Of Pages:161 | $ 4485

Catheter-Directed Thrombolysis Market By Device Type (Infusion Catheters, Guidewires, Thrombolytic Agents, Ultrasound-Assisted Catheters, Accessories); By Indication (Deep Vein Thrombosis, Pulmonary Embolism, Peripheral Arterial Occlusion, Acute Limb Ischemia, Others); By End User (Hospitals, ASCs, Specialty Clinics, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Catheter-Directed Thrombolysis Market will witness a robust CAGR of 6.9%, valued at $518.4 million in 2024 , expected to appreciate and reach $779.3 million by 203... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Pediatric Cardiology Market By Product Type (Diagnostic Devices, Therapeutic Devices, Surgical Instruments); By Procedure (Non-Invasive Diagnosis, Interventional Cardiology, Surgical Cardiology); By End User (Children’s Hospitals, Multispecialty Hospitals, ASCs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pediatric Cardiology Market will witness a robust CAGR of 7.4% , valued at $3.12 billion in 2024 , and is expected to appreciate and reac... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

NTRK Fusion Gene Positive Advanced Solid Tumor Market By Treatment Type (Targeted Therapy, Chemotherapy & Radiotherapy, Immunotherapy); By Diagnostic Technology (NGS Panels, FISH, RT-PCR, IHC); By End User (Academic Institutions, Specialty Clinics, General Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global NTRK Fusion Gene Positive Advanced Solid Tumor Market will witness a robust CAGR of 12.3% , valued at $1.15 billion in 2024 , expected to... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Retinal Detachment Market By Treatment Type (Vitrectomy, Scleral Buckling, Pneumatic Retinopexy, Laser Photocoagulation); By Diagnostic Method (OCT, Fundus Photography, Ultrasound, Slit-Lamp Biomicroscopy); By End User (Hospitals, Ophthalmic Clinics, ASCs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Retinal Detachment Market will witness a robust CAGR of 11.54 % , valued at $ 7.65 billion in 2024 , expected to appreci... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Lung Cancer Surgery Market By Procedure Type (Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection); By Surgery Approach (Open Thoracotomy, Video-Assisted Thoracoscopic Surgery [VATS], Robotic-Assisted Thoracic Surgery [RATS]); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Cancer Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Lung Cancer Surgery Market will witness a robust CAGR of 7.3% , valued at $6.2 billion in 2024 , and is expected to appreciate and reach $10.1 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Chronic Heart Failure Market By Treatment Type (Pharmaceuticals [ACE Inhibitors, Beta Blockers, SGLT2 Inhibitors, ARBs, MRAs, Ivabradine, Others], Devices [CRT, ICDs, LVADs, Remote Monitoring]); By Disease Type (HFrEF, HFpEF); By End User (Hospitals, Cardiology Clinics, ASCs, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Heart Failure Market will witness a robust CAGR of 6.8% , valued at $15.4 billion in 2024 , expected to appreciate and reach $22.9 billion by 2030... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Head and Neck Cancer Therapeutics Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgical Intervention); By Cancer Type (Oral Cavity Cancer, Oropharyngeal Cancer, Laryngeal Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer, Salivary Gland Tumors); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Head a nd Neck Cancer Therapeutics Market will witness a robust CAGR of 10.7% , valued at $2.85 billion in 2024 , and is expected to appr... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Preterm Birth Prevention and Management Market By Product Type (Pharmaceutical Interventions, Diagnostic and Predictive Tools, Medical Devices and Monitoring Equipment, Neonatal ICU Infrastructure); By Risk Category (High-Risk Pregnancy Interventions, Low-to-Moderate Risk Surveillance); By End User (Hospitals & Maternity Clinics, Research & Academic Institutions, Homecare & Telehealth); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Preterm Birth Prevention And Management Market will witness a steady CAGR of 6.9%, valued at approximately $2.45 billion in 2024 , a... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Adult Spinal Deformity Market By Product Type (Surgical Devices, Orthotic Devices, Bone Grafts & Substitutes, Vertebral Augmentation); By Surgery Type (Open, Minimally Invasive); By End User (Hospitals, Specialty Centers, ASCs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Adult Spinal Deformity Market will witness a robust CAGR of 7.6% , valued at $2.42 billion in 2024 , expected to appreciate and reach $3.76 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Cryotherapy Market By Product Type (Cryosurgery Devices, Whole-Body Chambers, Localized Equipment, Cryogen Gases); By Application (Oncology, Pain Management, Sports Medicine, Aesthetic Rejuvenation); By End User (Hospitals, Ambulatory Centers, Sports & Wellness Clinics, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cryotherapy Market will witness a robust CAGR of 8.23 % , valued at $4.3 billion in 2024 , expected to appreciate and reach $7.1 ... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Vertebroplasty and Kyphoplasty Market By Product Type (Vertebroplasty Devices, Kyphoplasty Devices); By Application (Osteoporosis, Spinal Tumors, Trauma, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Region (North America, Europe, Asia Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Vertebroplasty and Kyphoplasty Market will witness a robust CAGR of 10.5% , valued at USD 1.35 ... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Cervical Dysplasia Market By Grade Type (Low-Grade Lesions, High-Grade Lesions, ASC-US); By Diagnostic Method (Pap Smear, HPV DNA Testing, Colposcopy, Biopsy, Liquid-Based Cytology, VIA); By End User (Hospitals, Gynecology Clinics, Diagnostic Labs, ASCs, Community Health Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cervical Dysplasia Market will witness a steady CAGR of 6.9% , valued at $1.34 billion in 2024 , expected to appreciate and reach $2.02 billion by... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Sex Reassignment Surgery Market By Procedure Type (Genital Surgery, Breast/Chest Surgery, Facial Surgery, Body Contouring); By Gender Transition (Male-to-Female, Female-to-Male); By End User (Hospitals, Ambulatory Surgical Centers, Gender Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sex Reassignment Surgery Market will witness a robust CAGR of 11.6% , valued at $1.45 billion in 2024 , and is expected to reach $3.13 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Pediatric Palliative Care Market By Care Type (Hospital-Based, Community-Based, Home-Based, Hospice-Based); By Condition Type (Cancer and Hematologic Disorders, Neuromuscular Diseases, Congenital Disorders, Cardiopulmonary Conditions, Metabolic and Rare Diseases); By Service Model (Inpatient Consultation, Outpatient Clinics, Multidisciplinary Coordination, Pain Management, Psychosocial Counseling); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pediatric Palliative Care Market will witness a robust CAGR of 9.6% , valued at USD 6.8 billion in 2024 , expected to appreciate and reac... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Vaginitis Therapeutics Market By Therapeutic Type (Antibiotics, Antifungals, Hormonal Therapy, Probiotics & Microbiome Therapeutics); By Route of Administration (Topical, Oral, Intravaginal); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vaginitis Therapeutics Market will witness a robust CAGR of 6.9% , valued at $3.12 billion in 2024 , and is expected to appreciate and reach $4.67 billion by 2030<... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Digital Neurotherapeutics Market By Product Type (Prescription Digital Therapeutics, Non-Prescription Neurotherapeutics); By Therapeutic Application (ADHD, Depression, Anxiety, Chronic Pain, Alzheimer's, Insomnia, Substance Use Disorders); By End User (Hospitals, Neurology Centers, Homecare Settings, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context
 

The Global Digital Neurotherapeutics Market is projected to reach $2.4 billion in 2024, and it is expected to grow at a CAGR of 23.5% to attain a market size of approxi... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Bone Spur Market By Product Type (Pharmacological Treatment, Surgical Tools & Devices, Orthopedic Implants & Accessories, Therapeutic Aids); By Application (Spinal Bone Spurs, Heel Spurs, Hip and Knee Osteophytes, Shoulder and Elbow Osteophytes, Others); By End User (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bone Spur Market will witness a moderate but steady CAGR of 5.8% , valued at approximately USD 1.92 billion in 2024 , and is expected to appreciate and reach USD 2... Read More

Published Date: OCT-2025 | No Of Pages:161 | $ 4485

Surgical Sphincteroplasty Market By Procedure Type (Primary Sphincteroplasty, Overlapping Sphincteroplasty, Muscle Transposition); By Surgical Approach (Open Surgery, Minimally Invasive Surgery); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Surgical Sphincteroplasty Market is projected to expand at a CAGR of 7.2% , valued at $1.12 billion in 2024 , and is exp... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Tinnitus Management Market By Product Type (Hearing Aids, Sound Masking Devices, Neuromodulation Devices, Tinnitus Apps); By Therapy Approach (Sound Therapy, Cognitive Behavioral Therapy, Pharmacological, Neuromodulation); By End User (Hospitals & ENT Clinics, Audiology Centers, Home Care, Military & Veterans); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tinnitus Management Market will witness a robust CAGR of 7.4% , valued at $2.57 billion in 2024 , expected to appreciate and reach $4.17 billion b... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Rotator Cuff Injury Treatment Market By Treatment Type (Surgical Treatments, Non-Surgical Treatments); By Injury Type (Partial-Thickness Tear, Full-Thickness Tear, Tendinopathy); By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rotator Cuff Injury Treatment Market will witness a robust CAGR of 6.8% , valued at $7.4 billion in 2024 , expected to appreciate and reach $11.0 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Varicose Vein Treatment Market By Treatment Type (Endovenous Ablation, Sclerotherapy, Vein Stripping, Ligation, Compression Therapy, Adhesive Closure); By End User (Hospitals, ASCs, Vein Clinics, Homecare); By Mode of Treatment (Minimally Invasive, Non-Invasive, Surgical); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Varicose Vein Treatment Market will witness a robust CAGR of 7.5 % , valued at $1.11 billion in 2024 , and is expected to appreciate and ... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Sclerotherapy Market By Type of Agent (Detergent-Based Sclerosants, Osmotic Agents, Chemical Irritants); By Treatment Type (Liquid, Foam, Ultrasound-Guided); By Application (Varicose Veins, Spider Veins, Hemorrhoids, Vascular Malformations); By End User (Hospitals, ASCs, Specialty Clinics, Dermatology Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sclerotherapy Market will witness a promising CAGR of 8.36 % , valued at $ 1.68 billion in 2024 , expected to appreciate... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Colorectal Surgery Market By Product Type (Stapling Devices, Sutures, Robotic Systems, Energy Devices, Others); By Surgery Type (Colorectal Cancer Surgery, Hemorrhoidectomy, Colectomy, Fistula Repair, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Colorectal Surgery Market will witness a robust CAGR of 6.9% , valued at $15.4 billion in 2024 , and is expected to appreciate and reach $23.1 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Claudin 18.2 Targeted Therapy Market By Product Type (Monoclonal Antibodies, Antibody-Drug Conjugates, CAR-T Cell Therapies); By Indication (Gastric and Gastroesophageal Junction Cancer, Pancreatic Cancer, Lung Adenocarcinoma, Others); By Therapeutic Modality (Antibody-Based Therapy, Bispecific Antibody Constructs, Cell Therapy, Small Molecule Inhibitors); By End User (Hospitals & Oncology Centers, Specialty Clinics, Academic & Research Institutions, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

1. Introduction and Strategic Context

The Global Claudin 18.2 Targeted Therapy Market will experience substantial momentum between 2024 and 2030, with an estimated value of around USD 1.8 billion in 2024, projected to reach US... Read More

Published Date: MAR-2025 | No Of Pages:181 | $ 4485

Menopause Market By Product Type (Hormone Replacement Therapy [HRT], Non-Hormonal Treatments, Herbal Supplements); By Treatment Option (Pharmacological, Non-Pharmacological); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Menopause Market is expected to be valued at $20.5 billion in 2024 , with projections to reach $34.5 billion by 2030 , growing at a CAGR of 8.5%Read More

Published Date: OCT-2025 | No Of Pages:157 | $ 4485

Mesotherapy Market By Product Type (Mesotherapy Solutions, Devices, Kits & Consumables); By Application (Aesthetic Enhancement, Hair Restoration, Pain Management, Scar & Stretch Mark Treatment, Fat and Cellulite Reduction); By End User (Aesthetic Clinics, Hospitals & Dermatology Centers, Home Use, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mesotherapy Market will witness a robust CAGR of 11.2% , valued at $768.4 million in 2024 , and is expected to appreciate and reach $1.44 billion by 2030 ... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Kyphosis Treatment Market By Treatment Type (Surgical Intervention, Non-Surgical Management); By Disease Type (Postural, Congenital, Scheuermann’s, Nutritional/Pathological); By End User (Hospitals, Specialty Clinics, ASCs, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Kyphosis Treatment Market will witness a robust CAGR of 6.8% , valued at $2.35 billion in 2024 , and is expected to appreciate and reach $3.5 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Diabetic Foot Ulcer Treatment Market By Product Type (Wound Care Dressings, Antibiotics, Biological Therapies, Others); By Treatment Modality (Topical Treatments, Surgical Interventions, Biological Therapies); By End-User (Hospitals, Clinics, Home Care, Long-term Care Facilities, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Diabetic Foot Ulcer Treatment Market is poised to experience substantial growth, with a CAGR of 5.6% , expected to rise from $2.6 billion in 2024 to reach... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Aortic Coarctation Market By Treatment Type (Surgical Repair, Balloon Angioplasty, Stent Implantation); By Age Group (Neonates and Infants, Children and Adolescents, Adults); By End User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aortic Coarctation Market will witness a promising CAGR of 7.4% , valued at USD 561.8 million in 2024 , expected to appreciate and reach USD 921.3 million by ... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Blepharoplasty Market By Procedure Type (Upper Eyelid Surgery, Lower Eyelid Surgery, Combination, Revision, Transconjunctival, Laser-Assisted); By Gender (Male, Female, Non-Binary); By End User (Hospitals, ASCs, Cosmetic Clinics, Medical Spas); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blepharoplasty Market will witness a robust CAGR of 7.2% , valued at approximately USD 4.3 billion in 2024 , and is expected to appreciate and reach USD 6.9 billio... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Achondrogenesis Market By Type (Achondrogenesis Type 1A, Type 1B, Type 2); By Diagnostic Modality (Genetic Testing, Ultrasound & Imaging, Amniocentesis, Carrier Screening); By End User (Hospitals, Diagnostic Labs, Genetic Counseling Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Achondrogenesis Market will witness a steady CAGR of 6.8% , valued at $164.3 million in 2024 , expected... Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Facial Palsy Market By Treatment Type (Surgical Procedures, Non-Surgical Therapies, Advanced Therapies); By Cause of Condition (Bell’s Palsy, Traumatic Injury, Congenital, Tumor-Induced, Infectious & Autoimmune); By End User (Hospitals, Specialty Clinics, Rehabilitation Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Facial Palsy Market will witness a robust CAGR of 6.9% , valued at $3.1 billion in 2024 , and is expected to appreciate and reach $4.6 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Dysphagia Management Market By Product Type (Thickening Agents and Nutritional Supplements, Feeding Tubes and Enteral Devices, Diagnostic and Monitoring Tools, Swallowing Therapy and Assistive Technologies); By Indication (Neurological Disorders, Head and Neck Cancer, GERD, Others); By End User (Hospitals and Specialty Clinics, Home Healthcare Settings, Rehabilitation Centers, Long-Term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dysphagia Management Market will witness a robust CAGR of 6.8% , valued at $4.75 billion in 2024 , expected to appreciate and reach $7.05 billion by 2030 ... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Osteosarcoma Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Surgery, Radiotherapy); By Route of Administration (Intravenous, Oral, Intra-arterial); By Patient Demographic (Pediatric, Young Adults, Adults); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Osteosarcoma Market will witness a robust CAGR of 6.8% , valued at $1.54 billion in 2024 , expected to appreciate and reach $2.30 billion by 2030 , confir... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Paraneoplastic Syndrome Market By Syndrome Type (Neurologic, Endocrine, Dermatologic, Hematologic, Others); By Diagnostic Modality (Serological Testing, Imaging Techniques, CSF Analysis, Electrophysiological Tests, Others); By Treatment Type (Immunosuppressive Therapy, Plasmapheresis and IVIG, Anti-Tumor Therapy, Monoclonal Antibody Therapy, Supportive Care); By End User (Hospitals & Clinics, Diagnostic Labs, Academic Institutes, Pharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Paraneoplastic Syndrome Market will witness a steady CAGR of 7.4% , valued at USD 412.7 million in 2024 , and is expected to appreciate and reach USD 675.9 million... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Brain Ischemia Market By Product Type (Diagnostics, Pharmaceuticals, Interventional Devices, Monitoring Equipment); By Type of Ischemia (Focal, Global, Silent, Chronic Hypoperfusion); By End User (Hospitals, Diagnostic Imaging Centers, ASCs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brain Ischemia Market is projected to grow at a robust CAGR of 6.9% , estimated to be valued at $5.2 billion in 2024 and anticipated to reach approximately $7.8 bi... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Heart Transplantation Therapeutics Market By Drug Class (Immunosuppressive Agents, Induction Therapies, Anti-infective Therapies, Others); By Therapy Stage (Pre-transplant Stabilization, Intra-operative Management, Post-transplant Maintenance); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Transplant Hospitals, Academic Medical Centers, Specialty Clinics, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Heart Transplantation Therapeutics Market will witness a robust CAGR of 9.1% , valued at $1.38 billion in 2024 , and is expected to appreciate and reach $2.58 bill... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Myocardial Ischemia Market By Product Type (Pharmaceuticals, Medical Devices, Digital Health Solutions); By Diagnostic Modality (ECG, Stress Testing, MPI, CCTA, MRI); By Treatment Setting (Hospitals, ASCs, Diagnostic Centers, Telehealth); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myocardial Ischemia Market will witness a robust CAGR of 7.93 % , valued at $4.3 billion in 2024 , and is expected to appreciate and reach $Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Astigmatism Market By Product Type (Eyeglasses, Contact Lenses [Toric, RGP, Ortho-K], Surgical Systems [LASIK, PRK, SMILE], Intraocular Lenses); By Treatment Type (Non-Surgical Correction, Surgical Correction); By End User (Hospitals, ASCs, Optical Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Astigmatism Market will witness a robust CAGR of 8.9% , valued at USD 3.9 billion in 2024 , and is expected to appreciate and reach USD 6.5 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:181 | $ 4485

Myocardial Infarction Market By Treatment Type (Thrombolytic Therapy, Antiplatelet Agents, Beta Blockers, ACE Inhibitors, Statins, Coronary Angioplasty & Stenting, CABG); By Diagnosis (ECG, Biomarkers, Echocardiography, Angiography, Cardiac MRI); By End User (Hospitals & Cardiac Care Centers, ASCs, Labs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Myocardial Infarction Market will witness a robust CAGR of 7.21 % , valued at $17.8 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Tachycardia Market By Treatment Type (Pharmacological Therapy, Device-Based Therapy, Ablation Procedures, Electrical Cardioversion); By Tachycardia Type (SVT, AF, VT, Sinus Tachycardia, Others); By End User (Hospitals, Cardiology Clinics, ASCs, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tachycardia Market will witness a robust CAGR of 7.8% , valued at $9.6 billion in 2024 , expected to appreciate and reach $15.1 billion by 2030 , con... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Amblyopia Market By Treatment Type (Eyeglasses, Eye Patches, Atropine Drops, Vision Therapy, Digital Therapeutics); By Age Group (0–6 Years, 7–12 Years, 13–17 Years, Adults); By End User (Hospitals, Ophthalmology Clinics, Homecare Settings, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Amblyopia Market will witness a robust CAGR of 7.8% , valued at $4.6 billion in 2024 , expected to appreciate and reach $7.2 billion by 2030 , confir... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485

Uveal Melanoma Market By Treatment Type (Radiation Therapy, Immunotherapy, Liver-Directed Therapy, Targeted Therapy, Surgical Intervention); By Disease Stage (Localized, Metastatic); By Route of Administration (Oral, Intravenous, Intraocular, Hepatic Arterial); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Uveal Melanoma Market is projected to experience a moderate but significant growth trajectory, expanding at a CAGR of 6.8 % during the forecast period. It... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Mitochondrial-Based Therapeutics Market By Therapy Type (Small Molecule Drugs, Gene Therapies, Peptide-Based Therapeutics, Mitochondrial Replacement Therapies); By Application (Neurology, Metabolic Disorders, Cardiology, Oncology, Inherited Mitochondrial Diseases); By End User (Biopharmaceutical Companies, Academic & Research Institutes, Specialty Hospitals & Clinics, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Mitochondrial-Based Therapeutics Market will witness a robust CAGR of 10.8%, valued at USD 1.7 billion in 2024, expected to reach around USD 3.5 billion by 2030... Read More

Published Date: MAY-2025 | No Of Pages:156 | $ 4485

MENIN Inhibitors Market By Drug Type (Single-Agent MENIN Inhibitors, Combination MENIN Inhibitors); By Indication (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Other Indications); By Route of Administration (Oral, Intravenous); By End User (Hospitals & Oncology Centers, Specialty Clinics, Research Institutes, Pharmacies & Distributors); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

1. Introduction and Strategic Context

The Global MENIN Inhibitors Market is projected to expand steadily at an CAGR of 8.9%, valued at USD 520.2 million in 2024 and anticipated to surpass USD 872.1 million by ... Read More

Published Date: MAY-2025 | No Of Pages:185 | $ 4485

CDK 12 Inhibitors Market By Product Type (Small-Molecule Inhibitors, Combination Formulations); By Application (Triple-Negative Breast Cancer, Ovarian Cancer, Prostate Cancer, Others); By End User (Hospitals, Specialty Oncology Clinics, Academic & Research Institutes, Clinical Trial Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global CDK 12 Inhibitors Market is poised to witness a robust CAGR of 11.3%, valued at approximately USD 0.9 billion in 2024, and is expected to reach USD 1.7 billion ... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Interstitial Cystitis Market By Product Type (Oral Medications, Intravesical Therapies, Medical Devices & Diagnostics); By Route of Administration (Oral, Intravesical, Parenteral & Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Interstitial Cystitis Market will witness an estimated CAGR of 6.8%, valued at $1.43 billion in 2024, and projected to reach $2.13 billion by 2030, confirms Strategic Market Research.

 Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Critical Care Therapeutics Market By Product Type (Anti-infectives, Vasopressors, Sedatives, Neuromuscular Blockers, Corticosteroids, Biologics); By Therapeutic Area (Sepsis, Respiratory Failure, Trauma, Cardiac Arrest, Post-operative Complications); By Route of Administration (Intravenous, Intramuscular, Intranasal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Critical Care Therapeutics Market is projected to reach nearly 84.5 billion dollars by 2030 , rising from an estimated 56.3 billion dollars in 2024 . T... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Premature Ejaculation Treatment Market By Treatment Type (Topical Agents, Oral Therapies, Behavioral Therapy, Others); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Premature Ejaculation ( PE ) Treatment Market will witness a modest CAGR of 5.6%, valued at USD 1.47 billion in 2024, and is expected to reach USD 2.04 billion by 2030,... Read More

Published Date: SEP-2025 | No Of Pages:188 | $ 4485

Mycosis Fungoides Treatment Market By Treatment Type (Biologic Therapy, Phototherapy, Chemotherapy, Topical Treatments); By Therapy Method (Systemic Therapy, Localized Therapy); By End User (Hospitals, Specialty Clinics, Research Institutes, Diagnostic Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Mycosis Fungoides Treatment Market is poised for steady growth, with a projected compound annual growth rate (CAGR) of approximately 6.3% from 2024 to ... Read More

Published Date: SEP-2025 | No Of Pages:178 | $ 4485

Lateral Epicondylitis Treatment Market By Treatment Type (Pharmacological Therapy, Physical Therapy and Bracing, Minimally Invasive Procedures, Surgical Intervention); By End User (Hospitals, Orthopedic Clinics, Rehabilitation Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Lateral Epicondylitis Treatment Market is expected to grow steadily between 2024 and 2030, reaching an estimated valuation of USD 1.7 billion by 2030 from around USD 1.2 billion... Read More

Published Date: SEP-2025 | No Of Pages:195 | $ 4485

PKMYT1 Inhibitors Market By Indication (Ovarian Cancer, Endometrial Cancer, Breast & Prostate, Other Solid Tumors); By Line of Therapy (Relapsed/Refractory, First-Line & Second-Line); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2035

1. Introduction and Strategic Context

The Global PKMYT1 Inhibitors Market is set to grow at a compelling pace, with a base-case forecast of USD 460 million by 2030, and an upside scenario projecting revenues to cross USD 1.1 b... Read More

Published Date: SEP-2025 | No Of Pages:150 | $ 4485

CTLA4 Inhibitors Market By Drug Type (Monotherapies, Combination Therapies); By Indication (Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Others); By End User (Hospitals, Specialty Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global CTLA4 Inhibitors Market is poised for significant growth, with an estimated market size of USD 4.5 billion in 2024, projected to expand at a CAGR of 10.8%Read More

Published Date: SEP-2025 | No Of Pages:190 | $ 4485

Vitiligo Treatment Market By Treatment Type (Topical Therapy, Oral Therapy, Light Therapy, Surgical Procedures); By Route of Administration (Topical, Oral, Injectable); By End User (Dermatology Clinics, Hospitals, Tele-dermatology, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Vitiligo Treatment Market is expected to reach approximately USD 2.1 billion by 2030 , growing from an estimated USD 1.2 billion in 2024 , at a project... Read More

Published Date: SEP-2025 | No Of Pages:166 | $ 4485

Throat Cancer Therapeutics Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgical Intervention); By Cancer Subtype (Laryngeal Cancer, Pharyngeal Cancer, Tonsil Cancer); By Route of Administration (Oral, Intravenous, Topical/Localized); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Throat Cancer Therapeutics Market is estimated to be valued at 6.1 billion dollars in 2024 , and is pr ojected to grow to 9.7 billion dollars by 2030 ,... Read More

Published Date: SEP-2025 | No Of Pages:160 | $ 4485

Pulmonary Edema Therapeutics Market By Drug Class (Diuretics, Vasodilators, ACE Inhibitors & ARBs, Others); By Indication (Cardiogenic Pulmonary Edema, Non-Cardiogenic Pulmonary Edema, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Pulmonary Edema Therapeutics Market is poised to grow steadily, with a CAGR of 6.8% from 2024 to 2030, and is projected to reach a market siz... Read More

Published Date: SEP-2025 | No Of Pages:169 | $ 4485

Phosphoinositide 3-Kinase Inhibitors Market By Drug Type (Idelalisib, Copanlisib, Alpelisib, Duvelisib, Others); By Application (Hematologic Cancers, Breast Cancer, Solid Tumors, Others); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Phosphoinositide 3-Kinase Inhibitors Market will witness a steady compound annual growth rate of 9.7 percent , valued at 1.56 billion dollars in 2024 and projected to r... Read More

Published Date: SEP-2025 | No Of Pages:197 | $ 4485

Malabsorption Syndrome Market By Type (Celiac Disease, Lactose Intolerance, Chronic Pancreatitis, Others); By Diagnostic Method (Endoscopy, Blood Tests, Stool Tests, Imaging); By Treatment Option (Enzyme Replacement Therapy, Gluten-Free Diet, Pharmacological Treatments); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Malabsorption Syndrome Market is expected to experience steady growth in the coming years, driven by increasing global awareness of gastrointestinal diseases, an aging population, and advances in diagnostic te... Read More

Published Date: SEP-2025 | No Of Pages:168 | $ 4485

Gastrointestinal Stromal Tumor Treatment Market By Drug Type (Tyrosine Kinase Inhibitors, Immunotherapy, Chemotherapy); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Oncology Clinics, Academic Medical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Gastrointestinal Stromal Tumor ( GIST ) Treatment Market is poised to expand at a CAGR of 7.9% , reaching USD... Read More

Published Date: SEP-2025 | No Of Pages:173 | $ 4485

RNAi Drug Delivery Market By Drug Type (siRNA, miRNA); By Delivery Platform (Lipid Nanoparticles, GalNAc Conjugates, Polymeric Carriers, Exosomes); By Application (Genetic & Rare Diseases, Oncology, Cardiovascular & Metabolic, Neurological Disorders); By Route of Administration (Intravenous, Subcutaneous, Intrathecal/Inhalable); By End User (Hospitals, Specialty Clinics, Homecare Settings, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global RNAi Drug Delivery Market is projected to grow at a compelling CAGR of 18.9% from 2024 to 2030 , rising from an estimated USD 1.47 billion in 2... Read More

Published Date: SEP-2025 | No Of Pages:189 | $ 4485

Neuromyelitis Optica Spectrum Disorder Market By Therapy Type (Monoclonal Antibodies, Corticosteroids & Immunosuppressants, Plasma Exchange Therapy); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Neuromyelitis Optica Spectrum Disorder Market is poised to expand at a CAGR of 8.7% , with a value of USDRead More

Published Date: SEP-2025 | No Of Pages:193 | $ 4485